<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="en">Medical Herald of the South of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Медицинский вестник Юга России</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2025-16-2-37-42</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1983</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>3.1.4. OBSTETRICS AND GYNECOLOGY</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>3.1.4. АКУШЕРСТВО И ГИНЕКОЛОГИЯ</subject></subj-group></article-categories><title-group><article-title>Angiotensinogen – a marker of non-developing pregnancy</article-title><trans-title-group xml:lang="ru"><trans-title>Ангиотензиноген – маркер неразвивающейся беременности</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0145-6934</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Оразмурадов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Orazmuradov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оразмурадов Агамурад Акмамедович, д.м.н., профессор кафедры акушерства и гинекологии с курсом перинатологии Медицинского института </p><p>Москва </p></bio><bio xml:lang="en"><p>Agamurad A. Orazmuradov, Dr. Sci. (Med.), Prof., Depart. of Obstetrics and Gynecology with a course of perinatology, Medical Institute </p><p>Moscow </p></bio><email xlink:type="simple">orazmurzdov_aa@rudn.university</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1232-5753</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сулейманова</surname><given-names>Ж. Ж.</given-names></name><name name-style="western" xml:lang="en"><surname>Suleymanova</surname><given-names>Zh. Zh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сулейманова Жасмина Жигерхановна, аспирант кафедры акушерства и гинекологии с курсом перинатологии Медицинского института </p><p>Москва </p></bio><bio xml:lang="en"><p>Zhasmin Zh. Suleymanova, Depart. of Obstetrics and Gynecology with a course of perinatology, Medical Institute </p><p>Moscow </p></bio><email xlink:type="simple">1042210350@pfur.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2585-5086</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузьмина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzmina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузьмина Екатерина Александровна, аспирант кафедры акушерства и гинекологии с курсом перинатологии Медицинского института </p><p>Москва </p></bio><bio xml:lang="en"><p>Ekaterina A. Kuzmina, Depart. of Obstetrics and Gynecology with a course of perinatology, Medical Institute </p><p>Moscow </p></bio><email xlink:type="simple">KuzyaKaterina@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3108-7044</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костин</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostin</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Костин Игорь Николаевич, д.м.н., профессор кафедры акушерства и гинекологии с курсом перинатологии Медицинского института </p><p>Москва </p></bio><bio xml:lang="en"><p>Igor N. Kostin, Dr. Sci. (Med.), Prof., Depart. of Obstetrics and Gynecology with a course of perinatology, Medical Institute </p><p>Moscow </p></bio><email xlink:type="simple">bigbee62@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9172-7560</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хаддад</surname><given-names>Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Haddad</surname><given-names>Kh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хаддад Халид, к.м.н., ассистент кафедры акушерства и гинекологии с курсом перинатологии Медицинского института </p><p>Москва </p></bio><bio xml:lang="en"><p>Khalid Haddad, Cand. Sci. (Med.), Assistant, Depart. Of Obstetrics and Gynecology with a course of perinatology, Medical Institute </p><p>Moscow </p></bio><email xlink:type="simple">haddad.khaled@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9646-0156</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Муковникова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mukovnikova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Муковникова Екатерина Васильевна, аспирант кафедры акушерства и гинекологии с курсом перинатологии Медицинского института </p><p>Москва </p></bio><bio xml:lang="en"><p>Ekaterina V. Mukovnikova, Depart. of Obstetrics and Gynecology with a course of perinatology, Medical Institute </p><p>Moscow </p></bio><email xlink:type="simple">mukovnikova1997@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Российский университет дружбы народов им. Патриса Лумумбы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia n. a. Patrice Lumumba</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>07</month><year>2025</year></pub-date><volume>16</volume><issue>2</issue><fpage>37</fpage><lpage>42</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Orazmuradov A.A., Suleymanova Z.Z., Kuzmina E.A., Kostin I.N., Haddad K., Mukovnikova E.V., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Оразмурадов А.А., Сулейманова Ж.Ж., Кузьмина Е.А., Костин И.Н., Хаддад Х., Муковникова Е.В.</copyright-holder><copyright-holder xml:lang="en">Orazmuradov A.A., Suleymanova Z.Z., Kuzmina E.A., Kostin I.N., Haddad K., Mukovnikova E.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1983">https://www.medicalherald.ru/jour/article/view/1983</self-uri><abstract><p>Objective: to investigate the effects of angiotensinogen on the endometrium in missed abortion. Materials and methods: a prospective cohort that included 212 women, 160 with missed abortion and 52 with progressing pregnancies at 6–12 weeks. In all participants, the average serum concentration of angiotensinogen was measured. Additionally, a morphological examination of the endometrium was performed in patients with missed abortion. Results: women with missed abortion had significantly lower angiotensinogen levels compared to those with progressing pregnancies. Based on the results of a nonparametric analysis, there was a direct correlation between low angiotensinogen levels and spiral artery thrombosis in missed abortion patients at 11–12 weeks (r=0,37, p&lt;0,01). Conclusion: these findings suggest that a decrease in angiotensinogen levels is associated with impaired angiogenesis in the endometrium and can lead to spiral artery thrombosis during on the endometrium in missed abortion.</p></abstract><trans-abstract xml:lang="ru"><p>Цель: изучение воздействия ангиотензиногена на эндометрий при неразвивающейся беременности. Материалы и методы: проспективное когортное исследование, в которое вошли 212 женщин, из которых 160 — с неразвивающимися, 52 — c прогрессирующими беременностями в сроке 6–12 недель. у всех респонденток, включённых в исследование, определялись средние концентрации ангиотензиногена в сыворотки крови. У пациенток с неразвивающейся беременностью также проводилось морфологическое исследование эндометрия. Результаты: у женщин с неразвивающейся беременностью наблюдалось существенно более низкое содержание ангиотензиногена по сравнению с пациентами c прогрессирующей беременностью. По результатам непараметрического анализа была выявлена прямая корреляционная зависимость между низким уровнем ангиотензиногена в сыворотке и тромбозом спиральных артерий у пациенток с неразвивающейся беременностью на сроке 11–12 недель (r=0,37, p&lt;0,01). Заключение: снижение концентрации ангиотензиногена связано с нарушением процесса ангиогенеза в эндометрии, обусловленное формированием тромбов в просвете спиральных артерий у пациенток с неразвивающейся беременностью в 11–12 недель гестации.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>неразвивающаяся беременность</kwd><kwd>эндометрий</kwd><kwd>спиральные артерии</kwd><kwd>ангиотензиноген</kwd><kwd>тромбоз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>missed abortion</kwd><kwd>endometrium</kwd><kwd>spiral arteries</kwd><kwd>angiotensinogen</kwd><kwd>thrombosis</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>According to Rosstat, the total fertility rate in Russia decreased to 1.41 in 2023, indicating a continuing trend toward depopulation. For natural population growth, this indicator should reach at least 2.1. Key objectives for improving the demographic situation include reducing reproductive losses, strengthening the reproductive health of the population, and identifying additional reserves for increasing birth rates [<xref ref-type="bibr" rid="cit1">1</xref>].</p><p>In most cases, routine examinations for non-developing pregnancy (NDP) fail to identify the primary etiology of early reproductive loss1. Approximately 15% of all clinically diagnosed pregnancies end in spontaneous miscarriage, with NDP accounting for more than 70% of spontaneous pregnancy losses occurring before 12 weeks of gestation2. Despite such high figures, the pathogenesis of NDP remains largely unknown3. The most frequently cited causes of miscarriage include structural chromosomal abnormalities of the conceptus, uterine malformations, hyperhomocysteinemia, and antiphospholipid syndrome [<xref ref-type="bibr" rid="cit2">2</xref>]. Adequate angiogenesis within the chorionic villi plays a crucial role in maintaining early pregnancy [<xref ref-type="bibr" rid="cit2">2</xref>]. Development of the fetoplacental complex during most of the first trimester occurs in a low-oxygen environment; placental circulation gradually establishes after the eighth week of gestation and becomes substantial only after 12 weeks [<xref ref-type="bibr" rid="cit2">2</xref>].</p><p>The delicate balance between coagulation and fibrinolysis is critical during early pregnancy [<xref ref-type="bibr" rid="cit3">3</xref>]. Plasminogen activator inhibitor-1 (PAI-1) and angiotensin-converting enzyme (ACE) play pivotal roles in the regulation of the fibrinolytic process. Multiple studies have reported an association between genetic polymorphisms in the PAI-1 and ACE genes and recurrent pregnancy loss [<xref ref-type="bibr" rid="cit3">3</xref>]. </p><p>Emerging evidence suggests that abnormal levels of angiotensinogen (AGT) substantially increase the incidence of reproductive loss and pregnancy complications [2–4]. By binding to the type I AGT receptor, AGT activates growth factors and intracellular signaling pathways that promote proliferation, angiogenesis, fibrosis, and trophoblast invasion [<xref ref-type="bibr" rid="cit4">4</xref>]. In addition, AGT, acting through the Mas receptor, induces vasodilation, thereby preventing thrombus formation in the spiral arteries [<xref ref-type="bibr" rid="cit3">3</xref>][<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>Thus, the detection of AGT in serum may serve as a novel approach for the early diagnosis of NDP [<xref ref-type="bibr" rid="cit5">5</xref>][<xref ref-type="bibr" rid="cit6">6</xref>].</p><p>The aim of the study was to evaluate the effects of AGT on the endometrium in cases of NDP.</p></sec><sec><title>Materials and Methods</title><p>A prospective cohort study was conducted involving 160 women with NDP and 52 women with viable pregnancies at gestational ages of up to 12 weeks. All participants with NDP were divided into three groups according to gestational age: Group I – 6–8 weeks (n = 54), Group II – 9–10 weeks (n = 54), and Group III – 11–12 weeks (n = 52). Women with viable pregnancies up to 12 weeks served as the control group (n = 52). Mean serum concentrations of AGT were measured in all participants. In the NDP groups, a morphological examination of the endometrium was additionally performed. Using statistical analysis, correlations between AGT concentration and structural changes in the endometrium were evaluated in patients with NDP.</p><p>The study was conducted at the clinical base of the Department of Obstetrics and Gynecology with a course in Perinatology, Medical Institute, Peoples’ Friendship University of Russia (RUDN University), between April and December 2023, in the gynecological department of V.M. Buyanov Municipal Clinical Hospital (Chief Physician – PhD A.V. Salikov; Head of Department – PhD O.A. Demina).</p><p>The inclusion criteria for patient selection were as follows: spontaneous conception; in the main three groups – diagnosis of non-developing intrauterine pregnancy confirmed by two consecutive ultrasound examinations; in the control group – diagnosis of progressing intrauterine pregnancy.</p><p>The exclusion criteria were as follows: multiple pregnancy, gestational age exceeding 12 weeks, and pregnancy achieved through assisted reproductive technologies.</p><p>Between 6 and 12 weeks of gestation, ultrasonographic examination was performed using an Alpinion E-Cube 15 system (ALPINION Company, South Korea) equipped with a single-crystal transducer. Ultrasound assessment included measurement of the gestational sac diameter, evaluation of yolk sac shape and size, and detection of embryonic cardiac activity with heart rate recording. Gestational age was determined based on crown–rump length.</p><p>To determine the mean serum AGT concentrations, mass spectrometry and chromatography techniques were used.</p><p>Endometrial specimens obtained surgically were fixed in a 10% formalin solution for 24 hours. Tissue fixation was performed using isopropyl alcohol, followed by preparation of histological sections with a thickness of 4–6 mm. The biopsies were subsequently stained with hematoxylin and eosin.</p><p>The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki of the World Medical Association (1964, revised in 2013) and was approved by the Ethics Committee of the RUDN University. Written informed consent was obtained from each participant prior to enrollment.</p><p>Statistical analysis was performed using IBM SPSS Statistics, version 26 for Windows (IBM Corporation, Somers, NY, USA). The Shapiro–Wilk test was applied to assess the normality of data distribution. Categorical variables are presented as absolute and relative frequencies, whereas continuous variables with normally distributed data are expressed as the mean (M) ± standard deviation. For non-normally distributed data, the median (Me) and interquartile range (Q1–Q3) were reported. Fisher’s exact test was used to evaluate differences between categorical variables, and the Mann–Whitney test was applied for continuous variables. The differences were considered statistically significant at p&lt;0.05.</p><p>Correlation analysis was performed using Spearman’s nonparametric method (R). The strength of association was interpreted as strong for absolute correlation coefficients (r) ≥ 0.7, moderate for r values between 0.3 and 0.69, and weak for r &lt; 0.3. Statistical significance was set at p &lt; 0.05.</p></sec><sec><title>Results</title><p>In the groups of women with NDP, the frequency of two pregnancy termination methods was analyzed: (1) ultrasound-guided vacuum aspiration of the gestational sac, and (2) sequential administration of 200 mg mifepristone followed 24 hours later by 800 µg misoprostol (Table 1).</p><p>Table 1 demonstrates that in the cohort of patients with NDP, the medical method of pregnancy termination predominated, accounting for 64.4%.</p><p>To determine plasma AGT concentrations in women from the study groups, a metabolomic analysis was performed. Statistically significant differences in AGT concentrations were identified between patients with NDP and those in the control group (Table 2).</p><p>As shown by the presented data, the mean serum AGT concentration in patients with NDP was significantly lower compared with women with ongoing pregnancies: 0.057 ± 0.047 ng/mL versus 0.405 ± 0.094 ng/mL in the control group (p &lt; 0.05).</p><p>Morphological examination revealed that the structure of the endometrium in patients with NDP could be classified into two histological types. The first morphological pattern was characterized by leukocytic infiltration of the stroma, fibrinoid necrosis, and thrombosis of the spiral arteries (Fig. 1). The second type showed no thrombosis in the lumen of the spiral arteries; however, stromal fibrosis, vascular wall hyalinosis, and edematous–dystrophic changes were observed (Fig. 2).</p><p>Thus, the primary distinguishing feature between the two histological patterns was the presence or absence of spiral artery thrombosis.</p><p>We analyzed the share of cases with spiral artery thrombosis among patients with NDP (Table 3).</p><p>As shown in the presented data, the incidence of spiral artery thrombosis among women with NDP was twice as high at 11–12 weeks of gestation (p = 0.01).</p><p>To assess the association between spiral artery thrombosis and serum AGT levels in patients with NDP, a correlation analysis was performed using Spearman’s nonparametric method (Table 4).</p><p>Analysis of Table 4 revealed a direct correlation between serum AGT concentration and the presence of spiral artery clots in patients with NDP at 11–12 weeks of gestation (R = 0.37, p &lt; 0.01).</p><fig id="fig-1"><caption><p>Рисунок 1. Срез эндометрия: лейкоцитарная инфильтрация стромы, фибриноидный некроз, тромбоз спиральных артерий. Окраска гематоксилин-эозином, увеличение 250×.</p><p>Figure 1. Endometrial section: leukocyte infiltration of the stroma, fibrinoid necrosis, thrombosis of the spiral arteries. Hematoxylin-eosin staining, magnification 250×.</p></caption><graphic xlink:href="mvjr-16-2-g001.png"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/mvjr/2025/2/RPzRDew4HXS7pF02jmqU5bwiE3Ix3tKRBuqHdqkC.png</uri></graphic></fig><fig id="fig-2"><caption><p>Рисунок 2. Фрагмент эндометрия с фиброзом стромы, гиалинозом стенок спиральных артерий и отечно-дистрофическими изменениями. Окраска гематоксилин-эозином, увеличение 250×.</p><p>Figure 2. A fragment of the endometrium with stromal fibrosis, hyalinosis of the walls of the spiral arteries and edematous-dystrophic changes. Hematoxylin-eosin staining, magnification 250×.</p></caption><graphic xlink:href="mvjr-16-2-g002.png"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/mvjr/2025/2/s1EfDTF56e5zlXg9hyXmd1IzDC3nKFRzJWg0J4UC.png</uri></graphic></fig></sec><sec><title>Discussion</title><p>Despite a notable increase in research aimed at identifying biomarkers of NDP in recent years, the issue of predicting early pregnancy loss remains unresolved. To date, several serological, inflammatory, immunological, and oxidative stress markers have been identified, each demonstrating a certain degree of prognostic value [7–10].</p><p>The role of AGT in the pathogenesis of NDP during early pregnancy requires further investigation. Heidari et al. (2019) reported findings that appear to contrast with those obtained in the present study [<xref ref-type="bibr" rid="cit11">11</xref>]. The authors demonstrated that AGT gene polymorphism was a genetic determinant of the risk of developing idiopathic NDP. However, they also found that increased serum AGT concentrations correlated directly and proportionally with the risk of NDP [<xref ref-type="bibr" rid="cit11">11</xref>].</p><p>In our study, decreased AGT levels were associated with an increased risk of NDP, which is fully consistent with the findings of Xiong et al. (2021) [<xref ref-type="bibr" rid="cit10">10</xref>]. The authors investigated the correlation between recurrent pregnancy loss and the prevalence of AGT gene polymorphism. The proposed pathogenic mechanism involves thrombosis of the spiral arteries, leading to hypoxia and impairing adequate trophoblast invasion [<xref ref-type="bibr" rid="cit10">10</xref>].</p></sec><sec><title>Conclusion</title><p>The findings of this study suggest a direct association between decreased serum AGT levels and the risk of NDP. Reduced AGT concentrations appear to be linked to impaired angiogenesis within the endometrium, a process likely driven by the formation of clots within the lumina of spiral arteries in patients with NDP at 11–12 weeks of gestation.</p><p>1. Non-developing pregnancy. 3rd ed., revised and enlarged. Edited by V.E. Radzinsky. Moscow: GEOTAR-Media, 2019. 178 p. (in Russian).
2. History of undeveloped pregnancy: rehabilitation and preparation for the next gestation. Methodical recommendations of MARS (Interdisciplinary Association of Specialists in Reproductive Medicine). Version 2.0. Moscow: Editorial office of the journal StatusPraesens, 2021. 68 p. (in Russian).
3. Early pregnancy. From pregravidar preparation to healthy gestation / Edited by V.E. Radzinsky, A.A. Orazmuradova. 3rd ed., revised and enlarged. Moscow: Editorial office of the journal StatusPraesens, 2020. 798 p. (in Russian).
</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алешкина О.С., Коновалов О.Е. Мнение акушеровгинекологов о проблемах реабилитации женщин с ранними репродуктивными потерями. Российский медикобиологический вестник им. академика И.П. Павлова. 2024;32(1):17-24. https://doi.org/10.17816/PAVLOVJ566777</mixed-citation><mixed-citation xml:lang="en">Aleshkina O.S., Konovalov O.E. Opinion of Obstetricians and Gynecologists on Problems of Rehabilitation of Women with Early Reproductive Losses. I.P. Pavlov Russian Medical Biological Herald. 2024;32(1):17-24. (In Russ.) https://doi.org/10.17816/PAVLOVJ566777</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Biyik I, Albayrak M, Keskin F. Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Missed Abortion. Rev Bras Ginecol Obstet. 2020;42(5):235-239. https://doi.org/10.1055/s-0040-1709693</mixed-citation><mixed-citation xml:lang="en">Biyik I, Albayrak M, Keskin F. Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Missed Abortion. Rev Bras Ginecol Obstet. 2020;42(5):235-239. https://doi.org/10.1055/s-0040-1709693</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tamanna S, Morosin SK, Delforce SJ, van Helden DF, Lumbers ER, Pringle KG. Renin-angiotensin system (RAS) enzymes and placental trophoblast syncytialisation. Mol Cell Endocrinol. 2022;547:111609. https://doi.org/10.1016/j.mce.2022.111609</mixed-citation><mixed-citation xml:lang="en">Tamanna S, Morosin SK, Delforce SJ, van Helden DF, Lumbers ER, Pringle KG. Renin-angiotensin system (RAS) enzymes and placental trophoblast syncytialisation. Mol Cell Endocrinol. 2022;547:111609. https://doi.org/10.1016/j.mce.2022.111609</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hashem A, Sarsam SD. The Impact of Incidental Ultrasound Finding of Subchorionic and Retroplacental Hematoma in Early Pregnancy. J Obstet Gynaecol India. 2019;69(1):43-49. https://doi.org/10.1007/s13224-017-1072-6</mixed-citation><mixed-citation xml:lang="en">Hashem A, Sarsam SD. The Impact of Incidental Ultrasound Finding of Subchorionic and Retroplacental Hematoma in Early Pregnancy. J Obstet Gynaecol India. 2019;69(1):43-49. https://doi.org/10.1007/s13224-017-1072-6</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Хаддад Х., Оразмурадов А.А., Сулейманова Ж.Ж., Демина О.А., Морозов С.Г., Крылова Ю.В. Патогенетические аспекты неразвивающейся беременности. Акушерство и гинекология: новости, мнения, обучение. 2023;11(Спецвыпуск):139-143. https://doi.org/10.33029/2303-9698-2023-11-suppl-139-143</mixed-citation><mixed-citation xml:lang="en">Haddad Kh., Orazmuradov A.A., Suleymanova Zh.Zh., Demina O.A., Morozov S.G., Krylova Yu.V. Pathogenetic aspects of missed pregnancy. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie [Obstetrics and Gynecology: News, Opinions, Training]. 2023;11(Supplement):139–143. (In Russ.) https://doi.org/10.33029/2303-9698-2023-11-suppl-139-143</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Утробин М.В., Юрьев С.Ю. Иммунологические и генетические изменения как предикторы потери беременности при формировании ретрохориальной гематомы в первом триместре. Acta Biomedica Scientifica. 2018;3(5):9-15. https://doi.org/10.29413/ABS.2018-3.5.1</mixed-citation><mixed-citation xml:lang="en">Utrobin M.V., Yuryev S.Yu. Immunological and genetic changes as predictors in the loss of pregnancy in the formation of retrochorial hematoma in the first trimester. Acta Biomedica Scientifica. 2018;3(5):9-15. (In Russ.) https://doi.org/10.29413/ABS.2018-3.5.1</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lima J, Cambridge G, Vilas-Boas A, Martins C, Borrego LM, Leandro M. Serum markers of B-cell activation in pregnancy during late gestation, delivery, and the postpartum period. Am J Reprod Immunol. 2019;81(3):e13090. https://doi.org/10.1111/aji.13090</mixed-citation><mixed-citation xml:lang="en">Lima J, Cambridge G, Vilas-Boas A, Martins C, Borrego LM, Leandro M. Serum markers of B-cell activation in pregnancy during late gestation, delivery, and the postpartum period. Am J Reprod Immunol. 2019;81(3):e13090. https://doi.org/10.1111/aji.13090</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, et al. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. Atherosclerosis. 2017;267:49-60. https://doi.org/10.1016/j.atherosclerosis.2017.10.025</mixed-citation><mixed-citation xml:lang="en">Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, et al. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism. Atherosclerosis. 2017;267:49-60. https://doi.org/10.1016/j.atherosclerosis.2017.10.025</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Петров Ю.А., Блесманович А.Е., Алехина А.Г. Гипофункция щитовидной железы и беременность. Современные проблемы науки и образования. 2018;(5):4. eLIBRARY ID: 36367792 EDN: YMRKBV</mixed-citation><mixed-citation xml:lang="en">Petrov Yu.A., Blesmanovich A.E., Alyokhina A.G. Thyroid hypofunction and pregnancy. Modern problems of science and education. 2018;(5):4. (In Russ.) eLIBRARY ID: 36367792 EDN: YMRKBV</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Xiong YM, Pan HT, Ding HG, He Y, Zhang J, et al. Proteomic and functional analysis of proteins related to embryonic development of decidua in patients with recurrent pregnancy loss†. Biol Reprod. 2021;105(5):1246-1256. https://doi.org/10.1093/biolre/ioab140</mixed-citation><mixed-citation xml:lang="en">Xiong YM, Pan HT, Ding HG, He Y, Zhang J, et al. Proteomic and functional analysis of proteins related to embryonic development of decidua in patients with recurrent pregnancy loss†. Biol Reprod. 2021;105(5):1246-1256. https://doi.org/10.1093/biolre/ioab140</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Heidari MM, Sheikholeslami M, Yavari M, Khatami M, Seyedhassani SM. The association of renin-angiotensinogen system genes polymorphisms and idiopathic recurrent pregnancy loss. Hum Fertil (Camb). 2019;22(3):164-170. https://doi.org/10.1080/14647273.2017.1388545</mixed-citation><mixed-citation xml:lang="en">Heidari MM, Sheikholeslami M, Yavari M, Khatami M, Seyedhassani SM. The association of renin-angiotensinogen system genes polymorphisms and idiopathic recurrent pregnancy loss. Hum Fertil (Camb). 2019;22(3):164-170. https://doi.org/10.1080/14647273.2017.1388545</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
